Endocrinol Metab.  2018 Mar;33(1):135-136. 10.3803/EnM.2018.33.1.135.

Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea (Endocrinol Metab 2017;32:399-406, Tae Yong Kim et al.)

• Sun H
• Dionigi G

• KMID: 2407131
• DOI: http://doi.org/10.3803/EnM.2018.33.1.135

Abstract

No abstract available.

MeSH Terms

Korea*
Thyroid Gland*

Reference

1. Kim TY, Shong YK. Active surveillance of papillary thyroid microcarcinoma: a mini-review from Korea. Endocrinol Metab (Seoul). 2017; 32:399–406.

2. Kim HI, Jang HW, Ahn HS, Ahn S, Park SY, Oh YL, et al. High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance. J Clin Endocrinol Metab. 2018; 103:446–451.

3. Miyauchi A, Ito Y, Oda H. Insights into the management of papillary microcarcinoma of the thyroid. Thyroid. 2018; 28:23–31.

4. Oda H, Miyauchi A, Ito Y, Yoshioka K, Nakayama A, Sasai H, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016; 26:150–155.

5. An JH, Kim HY, Kim SG, Dralle H, Randolph GW, Piantanida E, et al. Endpoints for screening thyroid cancer in the Republic of Korea: thyroid specialists' perspectives. J Endocrinol Invest. 2017; 40:683–685.